Kristi Helen Piehl

Title: **Kristi Helen Piehl: Innovator in Biopharmaceuticals**

Introduction

Kristi Helen Piehl is a prominent inventor based in San Diego, California, recognized for her significant contributions to the field of biopharmaceuticals. With a total of 22 patents to her name, she has made considerable advancements in the development of novel therapeutics that harness the potential of histidyl-tRNA synthetase.

Latest Patents

Two of her latest patents showcase her innovative work. The first patent, titled "Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities," focuses on isolated polynucleotides and polypeptides that offer unique biological functions, along with related compositions and methods. The second patent, "Histidyl-tRNA synthetase-Fc conjugates," presents HRS-Fc conjugates that enhance controlled release properties, stability, half-life, and overall pharmacokinetic and biological attributes compared to unmodified polypeptides. These inventions are pivotal for treating and diagnosing various medical conditions.

Career Highlights

Throughout her career, Kristi has worked with esteemed organizations such as Atyr Pharma, Inc. and Pangu Biopharma Limited. Her experiences in these companies have solidified her reputation as a skilled inventor in the realm of biopharmaceutical research and development.

Collaborations

Kristi has collaborated with notable colleagues, including Leslie Ann Greene and Ryan Andrew Adams. These partnerships have undoubtedly contributed to the advancement of her innovative projects and the successful filing of her patents.

Conclusion

Kristi Helen Piehl exemplifies the essence of innovation in the biopharmaceutical industry. Her groundbreaking patents and collaborations highlight her commitment to advancing medical science, creating a lasting impact on the treatment of various conditions through her inventive spirit and expertise.